Greystone Managed Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-131,881
Closed -$22M 84
2014
Q2
$22M Sell
131,881
-1,420
-1% -$253K 0.4% 67
2014
Q1
$26.5M Buy
133,301
+37,710
+39% +$7.12M 0.48% 60
2013
Q4
$18.3M Buy
+95,591
New +$17.8M 0.3% 69

Other funds holding CLB

Greystone Managed Investments's CLB Position: Q3 2014 in Review

Greystone Managed Investments sold out of Core Laboratories (CLB) in Q3 2014, closing a stake of 131,881 shares — an estimated $22M sold.

Greystone Managed Investments first reported a position in CLB in Q4 2013 and held it in 3 quarters. The position peaked at $26.5M in Q1 2014. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • Greystone Managed Investments reported no remaining Core Laboratories position as of Q3 2014 after selling out during the quarter.
  • Greystone Managed Investments sold 131,881 Core Laboratories shares in Q3 2014, an estimated $22M.
  • Greystone Managed Investments first reported a position in Core Laboratories in Q4 2013 and held it in 3 quarters.
  • Greystone Managed Investments's Core Laboratories position peaked at $26.5M in Q1 2014.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on Greystone Managed Investments's 13F filing for Q3 2014, filed 7 Nov 2014.